Clinical trial
Lifemel Honey to Reduce Leucopenia During Chemotherapy
NCT00243165 · Rambam Health Care Campus, Other · Unknown status
Key facts
| NCT number | NCT00243165 |
|---|---|
| Title | Lifemel Honey to Reduce Leucopenia During Chemotherapy |
| Official title | Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia |
| Lead sponsor | Rambam Health Care Campus, Other |
| Collaborators | Zuf Globus Laboratories Ltd. |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Behavioral |
| Interventions | Lifemel honey intake every day |
| Enrollment | 60 |
| Start date | Nov 1, 2005 |
| First posted | Oct 21, 2005 |
| Last update posted | Dec 7, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: